USFDA Approves Zydus Lifescience Ltd To Produce Bortezomib
May 3, 2022 17:25United States Food and Drug Administration (USFDA) gave the green flag to Zydus Lifescience Limited to commercialize its generic version of Bortezomib. According to the reports, USFDA approved the final license to Zydus on Tuesday, 3rd May 2022. Bortezomib is an injection used to treat certain types of cancer. According to a regulatory filing by […]
